Olema Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a sele…

Biotechnology
US, San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Olema Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Olema Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Olema Pharmaceuticals, Inc..

End of OLMA's Analysis
CIK: 1750284 CUSIP: 68062P106 ISIN: US68062P1066 LEI: - UEI: -
Secondary Listings
OLMA has no secondary listings inside our databases.